28 june 2024
Our eHealth team advised us yesterday of an international vulnerability relating to polyfill.io . This domain has become compromised and is spreading malware through a widespread supply chain attack, estimated to affect over 110,000 websites including major websites such as the BBC. The Polyfill site offered widely used bits of code for older browsers that allowed the use of modern Javascript features. Such code makes the work for web developers easier and allows compatibility with a broader range of browsers.
Websites that have used the Javascript code from Polyfill have been urged to remove such code immediately. The change occurred after a suspected Chinese firm purchased the domain in early 2024.
Tactuum have identified and are now testing a fix to remove all Polyfill code from the RDS site.. They will be deploying the fix on Monday 1 July along with other planned fixes and amendments. I will notify you of the timing of the deployment as soon as possible.
In the meantime, please ensure that you have up-to-date anti-virus software installed on your machines and personal devices.
NICE clinical guideline CG184 provides information on the investigation and management of gastro-oesophageal reflux disease (GORD) and dyspepsia in adults.
In most patients with GORD, adequate symptom control is the principal aim of treatment. Symptoms should be controlled by using the lowest dose of the most cost–effective agent (antacid, H2 receptor antagonist or proton pump inhibitor). An ‘on demand’ regimen is acceptable providing it is effective.
To indicate the category of a formulary medicine, updated sections adopt the following key:
Preferred list (P): First-line formulary choices.
Total list (T): Alternative choices when preferred list options not effective/not tolerated, or not indicated.
Specialist initiation (S1): Specialist initiation, or on the advice of a Consultant or Specialist Practitioner in this therapeutic area. Continuation in primary care is acceptable.
Specialist use only (S2): Supply via hospital, Homecare Service or a hospital based prescription (HBP) for dispensing by community pharmacy. Not prescribed in primary care setting.
NHSL Medicines Guidance